Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0025 USD | 0.00% | 0.00% | +92.31% |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+92.31% | 5.54K | |
-15.34% | 18.88B | |
-40.92% | 2.84B | |
+24.02% | 1.85B | |
+8.62% | 1.66B | |
+26.63% | 1.26B | |
-7.74% | 989M | |
-18.61% | 896M | |
-1.03% | 757M | |
-23.22% | 637M |
- Stock Market
- Equities
- HTGMQ Stock
- News HTG Molecular Diagnostics, Inc.
- Craig-Hallum Adjusts HTG Molecular Diagnostics' Price Target to $3 from $8, Keeps Buy Rating